C30H43NO4
Neat
481.7
(alphaS, 5alpha, 7alpha)-17-(Cyclopropylmethyl)-alpha-(1, 1-dimethylethyl)-4, 5-epoxy-18, 19-dihydro-3, 6-dimethoxy-alpha-methyl-6, 14-ethenomorphinan-7-methanol; RefChem:405788; Buprenorphine 3-O-Methyl Ether; 16524-65-5; Buprenorphine 3-O-Methyl Ether (1mg/ml in Acetonitrile); 3-O-Methylbuprenorphine; SCHEMBL14408880; DTXSID501020935; YW439G497A; RX 6021M; BUPRENORPHINE IMPURITY D [EP IMPURITY]; Buprenorphine 3-O-Methyl Ether (1 mg/ml in Acetonitrile); BUPRENORPHINE HYDROCHLORIDE IMPURITY D [EP IMPURITY]; (2S)-2-[(1S, 2S, 6R, 14R, 15R, 16R)-5-(cyclopropylmethyl)-11, 15-dimethoxy-13-oxa-5-azahexacyclo[13.2.2.12, 8.01, 6.02, 14.012, 20]icosa-8(20), 9, 11-trien-16-yl]-3, 3-dimethylbutan-2-ol; (2S)-2-[17-(cyclopropylmethyl)-4, 5alpha-epoxy-3, 6-dimethoxy-6alpha, 14-ethano-14alpha-morphinan-7alpha-yl]-3, 3-dimethylbutan-2-ol (3-O-methylbuprenorphine); 6, 14-endo-Ethanotetrahydrothebaine, 22-cyclopropyl-7alpha-(1-hydroxy-1, 2, 2-trimethylpropyl)-; 6, 14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1, 1-dimethylethyl)-4, 5-epoxy-18, 19-dihydro-3, 6-dimethoxy-alpha-methyl-; 6, a14-aEthenomorphinan-a7-amethanol, 17-a(cyclopropylmethyl)a-aI+/--a(1, a1-adimethylethyl)a-a4, a5-aepoxy-a18, a19-adihydro-a3, a6-adimethoxy-aI+/--amethyl-a, (I+/-S, a5I+/- and a7I+/-)a-
(2S)-2-[(1S, 2S, 6R, 14R, 15R, 16R)-5-(cyclopropylmethyl)-11, 15-dimethoxy-13-oxa-5-azahexacyclo[13.2.2.12, 8.01, 6.02, 14.012, 20]icosa-8(20), 9, 11-trien-16-yl]-3 and 3-dimethylbutan-2-ol
InChI=1S/C30H43NO4/c1-26(2,3)27(4,32)21-16-28-11-12-30(21,34-6)25-29(28)13-14-31(17-18-7-8-18)22(28)15-19-9-10-20(33-5)24(35-25)23(19)29/h9-10,18,21-22,25,32H,7-8,11-17H2,1-6H3/t21-,22-,25-,27+,28-,29+,30-/m1/s1